The More Things Change | GenomeWeb

The More Things Change

Premium

About 10 years ago, when I was a community college instructor, I started a course called "Biotechnology and Society." My goals were two-fold: I wanted to recruit non-traditional students and also to reach out to students who might otherwise never have the opportunity to learn how biotechnology was about to change their future. We lured those students in by promising them credit for taking a lab (which they did) and, of course, the cool and amazing topics we covered in a warm and friendly fashion.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.